ArticleBMC endocrine disorders2016

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.

Clare Jamookeeah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.